Data for: Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection

Published: 31 March 2020| Version 1 | DOI: 10.17632/ddsx5ksgmp.1
Contributor:
Charles Sande

Description

This dataset contains data from the different assays outlined in the paper. The variables are defined as follows: Data legend Variable Explanation ALS_ELISAG_P RSV F-specific IgG in ALS at baseline ALS_ELISAG_P7 RSV F-specific IgG in ALS 7 days post prime vaccination ALS_ELISAG_B RSV F-specific IgG in ALS pre boost vaccination ALS_ELISAG_B7 RSV F-specific IgG in ALS 7 days post boost vaccination ALS_ELISAA_P RSV F-specific IgA in ALS at baseline ALS_ELISAA_P7 RSV F-specific IgA in ALS 7 days post prime vaccination ALS_ELISAA_B RSV F-specific IgA in ALS pre boost vaccination ALS_ELISAA_B7 RSV F-specific IgA in ALS 7 days post boost vaccination SERUM_ELISAG_P RSV F-specific IgG in serum at baseline SERUM_ELISAG_P14 RSV F-specific IgG in serum 14 days post prime vaccination SERUM_ELISAG_B RSV F-specific IgG in serum pre boost vaccination SERUM_ELISAG_B14 RSV F-specific IgG in serum 14 days post boost vaccination SERUM_ELISAA_P RSV F-specific IgA in serum at baseline SERUM_ELISAA_P14 RSV F-specific IgA in serum 14 days post prime vaccination SERUM_ELISAA_B RSV F-specific IgA in serum pre boost vaccination SERUM_ELISAA_B14 RSV F-specific IgA in serum 14 days post boost vaccination NASAL_ELISAG_P RSV F-specific IgG in nasal sample at baseline NASAL_ELISAG_P14 RSV F-specific IgG in nasal sample 14 days post prime vaccination NASAL_ELISAG_B RSV F-specific IgG in nasal sample pre boost vaccination NASAL_ELISAG_B14 RSV F-specific IgG in nasal sample 14 days post boost vaccination NASAL_ELISAA_P RSV F-specific IgA in nasal sample at baseline NASAL_ELISAA_P14 RSV F-specific IgA in nasal sample 14 days post prime vaccination NASAL_ELISAA_B RSV F-specific IgA in nasal sample pre boost vaccination NASAL_ELISAA_B14 RSV F-specific IgA in nasal sample 14 days post boost vaccination ALS_PRNT_P RSV specific neutralising antibody titre in ALS at baseline ALS_PRNT_P7 RSV specific neutralising antibody titre in ALS 7 days post prime vaccination ALS_PRNT_B RSV specific neutralising antibody titre in ALS pre boost vaccination ALS_PRNT_B7 RSV specific neutralising antibody titre in ALS 7 days post boost vaccination

Files

Categories

Immunoassay

License